ABSTRACT
The interaction between leukemic cells and stromal cells of the bone marrow microenvironment has been shown to enhance leukemic cell survival during exposure to chemotherapeutic agents. In the current study we investigated whether association of B lineage acute lymphoblastic leukemic cells with human bone marrow stromal cells altered caspase activation during chemotherapy treatment. Following treatment with Ara-C or VP-16 in vitro, caspase 3 activity in leukemic cells was consistently reduced by co-culture of leukemic cells with human bone marrow stromal cell layers. These observations suggest that the protective effect of the bone marrow microenvironment on leukemic cells may be due, in part, to regulation of caspase 3 activity.
Subject(s)
Bone Marrow Cells/physiology , Caspases/metabolism , Cell Survival/drug effects , Precursor Cell Lymphoblastic Leukemia-Lymphoma/enzymology , Stromal Cells/physiology , Acute Disease , Antimetabolites, Antineoplastic/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Caspase 3 , Coculture Techniques , Cytarabine/pharmacology , Etoposide/pharmacology , Humans , Tumor Cells, CulturedABSTRACT
We report on a patient with Rothmund-Thomson syndrome (RTS) whose cytogenetic evaluation showed a normal karyotype with no evidence of trisomy mosaicism or chromosomal rearrangements. Cultured lymphocytes from the patient, her mother, and a control exposed to mitomycin C and diepoxybutane did not show increased sensitivity to the dialkylating agents. Unlike some previous reports, we found no evidence of a deficiency in nucleotide excision repair, as measured with the functional unscheduled DNA synthesis assay. Glycophorin A analysis of red blood cells for somatic mutation revealed suspiciously high frequencies of both allele loss and loss-and-duplication variants in the blood of the patient, a pattern consistent with observations in other RecQ-related human diseases, and evidence for clonal expansion of a mutant clone in the mother. Discrepant results in the literature may reflect true heterogeneity in the disease or the fact that a consistent set of tests has not been applied to RTS patients.
Subject(s)
Chromosome Fragility/genetics , Rothmund-Thomson Syndrome/genetics , Adult , Blood Group Antigens/genetics , Child , Child, Preschool , DNA Damage/drug effects , DNA Repair/genetics , Epoxy Compounds/pharmacology , Erythrocytes/metabolism , Erythrocytes/pathology , Female , Flow Cytometry , Glycophorins/genetics , Humans , Infant , Infant, Newborn , Karyotyping , Loss of Heterozygosity/genetics , Lymphocytes/cytology , Lymphocytes/drug effects , Lymphocytes/metabolism , Lymphocytes/pathology , Male , Mitomycin/pharmacology , Mutation/genetics , Rothmund-Thomson Syndrome/blood , Rothmund-Thomson Syndrome/pathologySubject(s)
Abnormalities, Multiple/genetics , Chromosomes, Human, Pair 7 , Gene Duplication , Prenatal Diagnosis , Trisomy/genetics , Abnormalities, Multiple/pathology , Female , Humans , Hypertelorism/genetics , Hypertelorism/pathology , In Situ Hybridization, Fluorescence , Micrognathism/genetics , Micrognathism/pathology , Phenotype , PregnancyABSTRACT
A newborn girl with ring chromosome 1 is described. The letter reports the chromosome analysis of peripheral blood lymphocytes with 46,XX,r(1)(p36.3q44) and evidence of ring instability in umbilical cord fibroblasts.
Subject(s)
Abnormalities, Multiple/genetics , Chromosomes, Human, Pair 1 , Ring Chromosomes , Female , Humans , Infant, NewbornABSTRACT
A 2-day-old infant was evaluated and suspected of having 22q11.2 deletion based on microcephaly, short and narrow palpebral fissures, a prominent nose with hypoplastic alae nasi, thin fingers, and a right aortic arch. He also had an imperforate anus, which is not in the del 22q11.2 syndrome. Karyotype analysis identified a ring 22, while fluorescence in situ hybridization (FISH) for the DiGeorge syndrome critical region identified a 22q deletion on the other homologue. The karyotype designation was 46,XY,r(22)(p13q13.3).ish del(22)(q11.2q11.2) (D22S75-). Both parents function in the mildly mentally retarded range. The father's karyotype was normal whereas the mother had the ring 22 that was inherited by her son. This is the first case reported for abnormalities on both 22 homologues.
Subject(s)
Abnormalities, Multiple/genetics , Chromosome Deletion , Chromosomes, Human, Pair 22 , Ring Chromosomes , Anus, Imperforate , Face/abnormalities , Humans , In Situ Hybridization, Fluorescence , Infant, Newborn , Karyotyping , Male , SyndromeABSTRACT
Amniocentesis on a 32-year-old woman at risk for trisomy 21 by maternal serum triple screen showed a 46,Y,inv(X) (p22.1q24) karyotype in all cells analyzed. A blood sample was obtained from the mother for cytogenetic evaluation. Since she had the same inversion, DNA replication studies were performed to determine if the X inactivation pattern was random or not, since skewed inactivation of the inverted X might suggest that the breakpoints disrupted functional genes. DNA replication studies demonstrated that 68% of mother's cells with the inverted X were active, suggesting random X inactivation. The random X inactivation pattern suggested that the inversion is probably balanced and should not affect the fetus. A normal male was delivered at 40 weeks gestation.
Subject(s)
Chromosome Inversion , Fetal Diseases/diagnosis , Prenatal Diagnosis , X Chromosome/genetics , Adult , Amniocentesis , Female , Fetal Diseases/genetics , Humans , Infant, Newborn , Karyotyping , Male , Phenotype , Pregnancy , Pregnancy OutcomeABSTRACT
BACKGROUND: Development of the culture of renal epithelial cells in a serum-free growth medium was driven by the need to examine the effects of hormones and other effector molecules on differentiated cell function without interference from the complex mixture of substances in serum. The present report details this laboratory's cumulative experience in the use of a defined growth medium for the propagation of epithelial cells from adult, fetal, and malignant human renal tissue. METHODS: Routine cell culture technology was used to determine the capability of a defined growth medium to support the growth of renal epithelial cells isolated by collagenase dissociation of tissue from adult and fetal kidneys, renal cell carcinoma, and Wilms' tumors. RESULTS: The defined growth medium formulation consistently allows the isolation and growth of transporting renal epithelial cells from both normal adult and fetal kidneys. This growth medium only rarely supports the growth of epithelial cells from renal cell carcinomas and Wilms' tumors. CONCLUSIONS: The method developed for the culture of human proximal tubule cells requires minimal cell culture expertise and equipment, and results in the repeatable isolation of transporting epithelial cell cultures that retain features of differentiated proximal tubule cells.
Subject(s)
Cell Culture Techniques , Culture Media, Serum-Free , Kidney/cytology , 1-Methyl-3-isobutylxanthine/pharmacology , Arginine/pharmacology , Carcinoma, Renal Cell/pathology , Cell Differentiation , Cell Division , Cyclic AMP/metabolism , Embryo, Mammalian , Epithelial Cells/cytology , Freeze Fracturing , Humans , Kidney Cortex/cytology , Kidney Neoplasms/pathology , Kidney Tubules, Proximal/cytology , Microscopy, Electron , Microscopy, Phase-Contrast , Parathyroid Hormone/pharmacology , Wilms Tumor/pathologyABSTRACT
Various types of cancer occur in peroxidase-rich target tissues of animals exposed to aryl alcohols and amines. Unlike biotransformation by cytochrome P450 enzymes, peroxidases activate most substrates by one-electron oxidation via radical intermediates. This work analyzed the peroxidase-dependent formation of phenoxyl radicals in HL-60 cells and its contribution to cytotoxicity and genotoxicity. The results showed that myeloperoxidase-catalyzed redox cycling of phenol in HL-60 cells led to intracellular formation of glutathionyl radicals detected as GS-DMPO nitrone. Formation of thiyl radicals was accompanied by rapid oxidation of glutathione and protein-thiols. Analysis of protein sulfhydryls by SDS-PAGE revealed a significant oxidation of protein SH-groups in HL-60 cells incubated in the presence of phenol/H2O2 that was inhibited by cyanide and azide. Additionally, cyanide- and azide-sensitive generation of EPR-detectable ascorbate radicals was observed during incubation of HL-60 cell homogenates in the presence of ascorbate and H2O2. Oxidation of thiols required addition of H2O2 and was inhibited by pretreatment of cells with the inhibitor of heme synthesis, succinylacetone. Radical-driven oxidation of thiols was accompanied by a trend toward increased content of 8-oxo-7,8-dihydro-2'-deoxyguanosine in the DNA of HL-60 cells. Membrane phospholipids were also sensitive to radical-driven oxidation as evidenced by a sensitive fluorescence HPLC-assay based on metabolic labeling of phospholipids with oxidation-sensitive cis-parinaric acid. Phenol enhanced H2O2-dependent oxidation of all classes of phospholipids including cardiolipin, but did not oxidize parinaric acid-labeled lipids without addition of H2O2. Induction of a significant hypodiploid cell population, an indication of apoptosis, was detected after exposure to H2O2 and was slightly but consistently and significantly higher after exposure to H2O2/phenol. The clonogenicity of HL-60 cells decreased to the same extent after exposure to H2O2 or H2O2/phenol. Treatment of HL-60 cells with either H2O2 or H2O2/phenol at concentrations adequate for lipid peroxidation did not cause a detectable increase in chromosomal breaks. Detection of thiyl radicals as well as rapid oxidation of thiols and phospholipids in viable HL-60 cells provide strong evidence for redox cycling of phenol in this bone marrow-derived cell line.
Subject(s)
Lipid Peroxidation/drug effects , Peroxidase/metabolism , Phenol/metabolism , Phenol/toxicity , Sulfhydryl Compounds/metabolism , 8-Hydroxy-2'-Deoxyguanosine , Apoptosis/drug effects , Ascorbic Acid/metabolism , DNA Damage , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/metabolism , Electron Spin Resonance Spectroscopy , Free Radicals/metabolism , HL-60 Cells , Humans , Hydrogen Peroxide/metabolism , Hydrogen Peroxide/toxicity , Oxidation-Reduction , Oxidative Stress , Phospholipids/metabolism , Potassium Cyanide/pharmacology , Sodium Azide/pharmacology , Substrate SpecificityABSTRACT
We describe two Prader-Willi syndrome (PWS) patients who exhibit maternal uniparental disomy (UPD) of chromosome 15 and unusual patterns of gene expression and DNA replication. Both were diagnosed during infancy as having PWS; however, their growth and development were atypical compared with others with this condition. Weight was below normal in the first patient, and height and development were within normal limits in the second individual. Hyperphagia and polyphagia were not evident in either patient. Genotypes at multiple genomic loci, allele-specific methylation, gene expression, and DNA replication were analyzed at D15S9 [ZNF127], D15S63 [PW71], SNRPN, PAR5, IPW, and D15S10 in these patients. The maternal imprint (based on the absence of gene expression, synchronous replication, and methylation of both alleles) was retained at SNRPN in these patients, as is the case in others with UPD. By contrast, cells from the first individual expressed PAR5 and ZNF127, whereas the second expressed a single IPW allele. Asynchronous DNA replication was observed in both patients at all loci, except SNRPN. These findings show that a subset of imprinted genes can be transcribed in some PWS patients with maternal UPD and that asynchronous DNA replication is coordinated with this pattern of gene expression. Relaxed imprinting in these patients is consistent with their milder phenotype.
Subject(s)
Chromosome Aberrations , Genomic Imprinting , Prader-Willi Syndrome/genetics , Adolescent , Alleles , Child , Chromosomes, Human, Pair 15/genetics , DNA Methylation , DNA Replication , Fathers , Female , Gene Expression , Genetic Markers , Humans , Male , Microsatellite Repeats , Mothers , Polymorphism, GeneticABSTRACT
We report on an infant with a karyotype of 46,XY,del(2) (p11.2p13), the fourth reported case in the literature. At birth, the child had eventration of the diaphragm. His phenotype was suggestive of a connective tissue disorder with scoliosis, pectus carinatum, long slender fingers, camptodactyly, cryptorchidism, hypertonia and myopia. His facial appearance was mildly dysmorphic and strongly resembled a previously reported patient with the same deletion. The child expired at 2 months of age. Some generalizations can be made about the phenotype for del(2)(p11.2p13), despite reporting of cases at different ages.
Subject(s)
Chromosome Aberrations , Chromosome Deletion , Chromosome Disorders , Chromosomes, Human, Pair 2/genetics , Marfan Syndrome , Chromosome Aberrations/genetics , Chromosome Aberrations/physiopathology , Craniofacial Abnormalities/genetics , Diaphragm/physiopathology , Humans , Infant, Newborn , Karyotyping , Male , Marfan Syndrome/geneticsABSTRACT
A 10 1/2-month-old boy was found to have an unbalanced karyotype, 45,XY,der(8)t(8;15) (p23.3;q13). One of 83 analyzed cells also contained an unidentified small marker. Fluorescence in situ hybridization (FISH) using cosmid probes for SNRPN, D15S10, and GABRB3 for the Prader-Willi syndrome (PWS)/Angelman syndrome (AS) critical region were not present on the derived chromosome. The child had some physical findings compatible with monosomy 8p. The mother also was a balanced carrier for the translocation. She also had 2/80 cells with an additional small marker chromosome, similar in size to the extra chromosome in the one cell of the propositus. FISH using an 8 paint did not show the reciprocal exchange on the der(15) but was demonstrated by using an 8p telomeric probe. At 18 months of age the child has some manifestations of AS. Earlier diagnosis may have been masked by the 8p- phenotype, or related to difficulty in diagnosing AS in infants.
Subject(s)
Angelman Syndrome/genetics , Translocation, Genetic , Humans , In Situ Hybridization, Fluorescence , Infant , Karyotyping , Male , Pedigree , Phenotype , Syndrome , TelomereABSTRACT
We report on a phenotypically normal girl with a deletion of the distal long arm of one X chromosome at Xq22, and spontaneous pubertal development including menarche. This suggests that the distal long arm of the X chromosome is not crucial for ovarian development. Cytogenetic and polymerase chain reaction (PCR) amplification methods both showed preferential inactivation of the deleted X chromosome. The PCR-based assay has the additional advantage of identifying the paternal origin of the deleted X chromosome.
Subject(s)
Chromosome Deletion , Dosage Compensation, Genetic , Puberty/physiology , X Chromosome , Child , Female , Humans , Karyotyping , Phenotype , Polymerase Chain Reaction , Turner Syndrome/physiopathologyABSTRACT
We have studied a 38-year-old man with a prior diagnosis of Holt-Oram syndrome, who presented with diabetes mellitus. He had recently taken prednisone for idiopathic interstitial lung disease and trimethoprim-sulfamethoxazole for sinusitis. Thrombocytopenia progressed to pancytopenia. The patient had skeletal, cardiac, renal, cutaneous, endocrine, hepatic, neurologic, and hematologic manifestations of Fanconi anemia (FA). Chest radiographs showed increased interstitial markings at age 25, dyspnea began in his late 20s, and he stopped smoking at age 32. At age 38, computerized tomography showed bilateral upper lobe fibrosis, lower lobe honeycombing, and bronchiectasis. Pulmonary function tests, compromised at age 29, showed a moderately severe obstructive and restrictive pattern by age 38. Serum alpha-1 antitrypsin level was 224 (normal 85-213) mg/dL and PI phenotype was M1. Karyotype was 46,XY with a marked increase in chromosome aberrations induced in vitro by diepoxybutane. The early onset and degree of pulmonary disease in this patient cannot be fully explained by environmental or known genetic causes. The International Fanconi Anemia Registry (IFAR) contains no example of a similar pulmonary presentation. Gene-environment (ecogenetic) interactions in FA seem evident in the final phenotype. The pathogenic mechanism of lung involvement in FA may relate to oxidative injury and cytokine anomalies.
Subject(s)
Fanconi Anemia/complications , Lung Diseases, Interstitial/etiology , Adult , Age of Onset , Fanconi Anemia/genetics , Fanconi Anemia/metabolism , Genetic Complementation Test , Humans , Karyotyping , Lung Diseases, Interstitial/diagnostic imaging , Lung Diseases, Interstitial/genetics , Lung Diseases, Interstitial/metabolism , Male , Mutation , Oxidative Stress , RadiographyABSTRACT
There are no widely applied definitive laboratory tests for the diagnosis of ataxia telangiectasia (AT). We, and others, have previously reported significantly elevated levels of in vivo somatic mutation in blood samples from known AT patients, observations that might form the basis for a useful prospective laboratory test for confirmation of a clinical diagnosis of AT. In the present case, a 4 1/2-year-old black female was suspected of having AT based on ataxic gait and chronic upper respiratory infections. Blood work-up showed low IgG2 and elevated alpha-fetoprotein (AFP), consistent with the AT phenotype. Her peripheral blood karyotype was normal, however, with no spontaneous breakage observed among 100 solid stained metaphases. Lymphocytes from AT patients often show elevated levels of chromosome rearrangement, especially at sites of immunoglobulin and T-cell receptor genes. Therefore, a blood sample was analyzed with the glycophorin A (GPA) in vivo somatic mutation assay. The GPA assay detects and quantifies the phenotypically variant erythrocytes resulting from loss of heterozygosity for the MN blood group. The patient had a 10-fold increased frequency of variant erythrocytes with a phenotype consistent with simple loss of the N allele, which is characteristic of AT. In addition, the variant cell distribution for this patient showed three other, more qualitative hallmarks of AT: a normal frequency of allele loss and duplication events, a unique ridge of cells of intermediate phenotype between the normal and mutant peaks, and evidence of similar ongoing mutational loss of the M allele. Together with clinical data, these distinctive qualitative and quantitative features of the GPA assay allow for a diagnosis of AT with a projected accuracy of 95%. Therefore, we suggest that the GPA assay, which can be performed on < 1 ml of blood and completed in less than a day, be considered as a confirmatory laboratory test for a clinical diagnosis of AT.
Subject(s)
Ataxia Telangiectasia/diagnosis , DNA Mutational Analysis , Glycophorins/genetics , MNSs Blood-Group System/genetics , Agammaglobulinemia/etiology , Alleles , Ataxia Telangiectasia/blood , Child, Preschool , Chromosome Aberrations , Erythrocytes, Abnormal , Female , Gene Duplication , Humans , Immunoglobulin G/blood , Karyotyping , Loss of Heterozygosity , Lymphocytes/ultrastructure , Respiratory Tract Infections/etiology , alpha-Fetoproteins/analysisABSTRACT
Myotonic dystrophy (DM) is a trinucleotide repeat syndrome which can contain 50 to over 2,000 CTG repeats in affected individuals, but does not express a fragile site. Although one prior study [Jalal et al., Am J Med Genet 46:441-443, 1993] did not find evidence of fragility at 19q13.3 in six individuals affected with DM using induction protocols for folate sensitive fragile sites, other chemicals may induce fragile site expression at this site. In an attempt to induce fragile sites at 19q13.3, blood cultures from four congenital DM cases and four control individuals treated with fluorodeoxyuridine (folate-sensitive rare fragile sites), bromodeoxyurdine (rare and common fragile sites), aphidicolin (common fragile sites), and 5-azacytidine (common fragile sites) were harvested using routine cytogenetic technique. Slides were solid stained and 100 cells were examined for fragile site expression, particularly on F group chromosomes. The latter were photographed prior to destaining and G-banded to verify chromosome and band location of breakage. No culture conditions induced a fragile site at band 19q13.3 at > 1% expression in patients with congenital DM. Our results suggest that CTG repeats, even when present in > 1,000 copies, may behave differently from other large expansions which are associated with fragile sites. The CTG repeats in DM are not associated with a methylated CpG island, as are folate-sensitive fragile sites, which most likely plays a role in the expression of fragile sites at the trinucleotide repetitive site.
Subject(s)
Chromosome Fragility , Myotonic Dystrophy/genetics , Repetitive Sequences, Nucleic Acid , Blotting, Southern , Cells, Cultured , Chromosome Banding , Chromosome Fragile Sites , Chromosomes, Human, Pair 19 , DNA/genetics , HumansABSTRACT
OBJECTIVE: In our general experience, about 2% of samples referred for fragile X testing showed positive results on Southern blot analysis. The aim of this project was to determine whether screening criteria could be developed to increase the proportion of positive test results without sacrificing sensitivity. STUDY DESIGN: We retrospectively analyzed nine clinical characteristics from patient records of 273 male and 62 female pediatric probands (average age, 5.7 years) referred for fragile X testing. The characteristics included mental retardation, family history of mental retardation, large or prominent ears, elongated face, attention deficit hyperactivity disorder, autistic-like behavior, simian crease, macroorchidism, and hyperextensible joints. These were scored as 2 if present, 1 If borderline present, and 0 if absent. RESULTS: Analysis of the nine characteristics identified three (simian crease, macroorchidism, and hyperextensible joints) with low frequency and statistical insignificance, which were therefore eliminated. With the use of the remaining six characteristics, If a score of 5 or more was used as the criterion for requesting fragle X testing, then close to 60% of those tests from our patient population could have been eliminated without missing any positive cases. The validity of our threshold score of 5 was subsequently confirmed among an additional six cases of fragile X syndrome. CONCLUSION: With our simplified six-item clinical checklist, 60% of testing could have been eliminated, thereby improving the cost-effectiveness of fragile X testing and increasing the proportion of cases with positive results by threefold.